Combination of loop diuretics with thiazide-type diuretics in heart failure

Journal of the American College of Cardiology

Volumn 56, Issue 19, 2010, Pages 1527-1534

  Jentzer, Jacob C ^a   Dewald, Tracy A ^a   Hernandez, Adrian F ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Abbreviations and Acronyms; CDT; combination diuretic therapy; LD; loop diuretic(s); TD; thiazide type diuretic(s)

Indexed keywords

ACETAZOLAMIDE; ALDOSTERONE ANTAGONIST; AMILORIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BUMETANIDE; BUTIZIDE; CHLOROTHIAZIDE; CONIVAPTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; QUINETHAZONE; SODIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; TORASEMIDE; TRIAMTERENE; VASOPRESSIN ANTAGONIST;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CREATININE CLEARANCE; DEHYDRATION; DISEASE SEVERITY; DIURESIS; DIURETIC THERAPY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG WITHDRAWAL; EDEMA; HEART ARRHYTHMIA; HEART FAILURE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERURICEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; HYPOVOLEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; LOW DRUG DOSE; METABOLIC ALKALOSIS; PRIORITY JOURNAL; SIDE EFFECT; SODIUM EXCRETION; SODIUM RETENTION; UREA NITROGEN BLOOD LEVEL; UREMIA;

EID: 78049332540     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.06.034     Document Type: Review

References (65)

1. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 480 486
2. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
3. G.M. Felker, P.S. Pang, and K.F. Adams Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2010 314 325
4. M. Metra, L. Dei Cas, and M.R. Bristow The pathophysiology of acute heart failureit is a lot about fluid accumulation Am Heart J 155 2008 1 5
5. G. Cotter, G.M. Felker, K.F. Adams, O. Milo-Cotter, and C.M. O'Connor The pathophysiology of acute heart failureis it all about fluid accumulation? Am Heart J 155 2008 9 18
6. G.M. Felker, C.M. O'Connor, and E. Braunwald Loop diuretics in acute decompensated heart failure: necessary? evil? A necessary evil? Circ Heart Fail 2 2009 56 62
7. W.F. Peacock, M.R. Costanzo, and T. DeMarco Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry Cardiology 113 2009 12 19
8. J. Butler, D.E. Forman, and W.T. Abraham Relationship between heart failure treatment and development of worsening renal function among hospitalized patients Am Heart J 147 2004 331 338 (Pubitemid 38176835)
9. G.W. Neuberg, A.B. Miller, and C.M. O'Connor Diuretic resistance predicts mortality in patients with advanced heart failure Am Heart J 144 2002 31 38
10. D.H. Ellison Diuretic therapy and resistance in congestive heart failure Cardiology 96 2001 132 143
11. G.H. Kim Long-term adaptation of renal ion transporters to chronic diuretic treatment Am J Nephrol 24 2004 595 605
12. D.H. Ellison The physiologic basis of diuretic synergism: its role in treating diuretic resistance Ann Intern Med 114 1991 886 894
13. N.R. Loon, C.S. Wilcox, and R.J. Unwin Mechanism of impaired natriuretic response to furosemide during prolonged therapy Kidney Int 36 1989 682 689
14. D.L. Vargo, W.G. Kramer, P.K. Black, W.B. Smith, T. Serpas, and D.C. Brater Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure Clin Pharmacol Ther 57 1995 601 609
15. D.A. Sica, and T.W. Gehr Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships Clin Pharmacokinet 30 1996 229 249
16. J.A. Goebel, and A.B. Van Bakel Rational use of diuretics in acute decompensated heart failure Curr Heart Fail Rep 5 2008 153 162
17. L. Dettli, and P. Spring Therapy with combinations of diuretic agents: comparative studies Ann N Y Acad Sci 139 1966 471 480
18. A.O. Robson, R. Ashcroft, D.N.S. Kerr, and G. Teasdale The diuretic response to frusemide Lancet 284 1964 1085 1088
19. K.H. Olesen, B. Dupont, and E. Flensted-Jensen The combined diuretic action of quinethazone and furosemide in congestive heart failure Acta Med Scand 187 1970 33 40
20. K.H. Olesen The natriuretic effect addition of quinethazone and furosemide in congestive heart failure A permutation trial test Acta Med Scand 190 1971 229 232
21. K.H. Olesen, and B. Sigurd The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone Permutation trial tests in patients with congestive heart failure Acta Med Scand 190 1971 233 240
22. P. Beck, and A.W. Asscher Clinical evaluation of metolazone (Zaroxylyn)a new quinazoline diuretic Clin Trials J 3 1971 13 18
23. R.F. Gunstone, A.J. Wing, H.G.P. Shani, D. Njemo, and E.M.W. Sabuka Clinical experience with metolazone in fifty-two African patients: synergy with frusemide Postgrad Med J 47 1971 789 793
24. A.W. Asscher Treatment of frusemide resistant edema with metolazone Clin Trials J 4 1974 134 139
25. B. Sigurd, K.H. Olesen, and A. Wennevold The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure Permutation trial tests in patients in long-term treatment with bumetanide Am Heart J 89 1975 163 170
26. M. Epstein, B.A. Lepp, and D.S. Hoffman Potentiation of furosemide by metolazone in refractory edema Curr Ther Res 21 1977 656 667
27. C.V.S. Ram, and M.J. Reichgott Treatment of loop-diuretic resistant edema by the addition of metolazone Curr Ther Resp 22 1977 686 691
28. B. Sigurd, and K.H. Olesen Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment of potent diuretic bumetanide Acta Med Scand 203 1978 113 119
29. J. Furrer, O.M. Hess, U. Kuhlmann, N. Satz, and W. Siegenthaler [Furosemide and metolazone: a highly effective diuretic combination] (German) Schweiz Med Wochenschr 110 1980 1825 1829
30. R.R. Ghose, and S.K. Gupta Synergistic action of metolazone with "loop" diuretics Br Med J 282 1981 1432 1433
31. J.M. Allen, C.R.K. Hind, and H.B. McMichael Reply to: "Synergistic action of metolazone with "loop" diuretics." Br Med J 282 1981 1873
32. J.M. Bamford Reply to: "Synergistic action of metolazone with "loop" diuretics." Br Med J 283 1981 618
33. I. Grosskopf, M. Rabinovitz, and J.B. Rosenfeld Combination of furosemide and metolazone in the treatment of severe congestive heart failure Isr J Med Sci 22 1986 787 790
34. J.S. Gage, D.M. Mancini, and W. Gumbardo Efficacy of combined diuretic therapy with metolazone and furosemide in patients with refractory congestive heart failure Cardio Rev Rep 7 1986 814 817
35. D.J. Aravot, N.R. Banner, and F. Musumeci Oral metolazone plus frusemide for home therapy in patients with refractory heart failure Lancet 333 1989 727
36. J.S. Friedland, and J.G.G. Ledingham Oral metolazone plus frusemide for home therapy in patients with refractory heart failure Lancet 333 1989 727 728
37. A. Kiyingi, M.J. Field, C.C. Pawsey, J. Yiannikas, J.R. Lawrence, and W.J. Arter Metolazone in treatment of severe refractory congestive cardiac failure Lancet 335 1990 29 31
38. K.S. Channer, M. Richardson, R. Crook, and J.V. Jones Thiazides with loop diuretics for severe congestive heart failure Lancet 335 1990 922 923
39. N. Krger, J. Szuba, and H. Frenzel [Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy] (German) Med Klin (Munich) 86 1991 305 308
40. T.P.J. Dormans, and P.G. Gerlag Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure J.B. Puschett, Diuretics IV: Chemistry, Pharmacology and Clinical Applications: Proceedings of the Fourth International Conference on Diuretics, Boca Raton, Florida, 11-16 October 1992 1993 Elsevier New York, NY 45 48
41. K.S. Channer, K.A. McLean, P. Lawson-Matthews, and M. Richardson Combination diuretic treatment in severe heart failure: a randomised controlled trial Br Heart J 71 1994 146 150
42. M. Mouallem, I. Brif, H. Mayan, and Z. Farfel Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions Int J Cardiol 50 1995 89 94
43. T.P.J. Dormans, and P.G. Gerlag Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure Eur Heart J 17 1996 1867 1874
44. F. Vanky, M. Broquist, and R. Svedjeholm Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations Ann Thorac Surg 63 1997 993 997
45. J. Rosenberg, F. Gustafsson, S. Galatius, and P.R. Hildebrandt Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature Cardiovasc Drugs Ther 19 2005 301 306
46. D.A. Sica Metolazone and its role in edema management Congest Heart Fail 9 2003 100 105
47. H. Knauf, and E. Mutschler Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure J Cardiovasc Pharmacol 26 1995 394 400
48. M. Tanaka, E. Oida, and K. Nomura The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema Clin Exp Nephrol 9 2005 122 126
49. D. Fliser, M. Schrter, M. Neubeck, and E. Ritz Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure Kidney Int 46 1994 482 488
50. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
51. G.L. Wollam, R.C. Tarazi, E.L. Bravo, and H.P. Dustan Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia Am J Med 72 1982 929 938
52. R.A. Lorenz, and R.J. Elwell Pre-dosing metolazone with loop diuretic combination regimens Nephrol Nurs J 33 2006 78 79
53. H. Knauf, E. Mutschler, H. Velazquez, and G. Giebisch Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis Eur J Clin Pharmacol 65 2009 465 472
54. R.H. Mehta, J.G. Rogers, and V. Hasselblad Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure Am J Cardiol 103 2009 76 81
55. B.M. Wertman, V. Gura, and E.R. Schwarz Ultrafiltration for the management of acute decompensated heart failure J Card Fail 14 2008 754 759
56. J.R. Oster, M. Epstein, and S. Smoller Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention Ann Intern Med 99 1983 405 406
57. H.A. Cooper, D.L. Dries, C.E. Davis, Y.L. Shen, and M.J. Domanski Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction Circulation 100 1999 1311 1315
58. L. Klein, C.M. O'Connor, and J.D. Leimberger Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study Circulation 111 2005 2454 2460
59. B. Dussol, J. Moussi-Frances, and S. Morange A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension Nephrol Dial Transplant 20 2005 349 353
60. R. de Silva, N.P. Nikitin, and K.K. Witte Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis Eur Heart J 27 2006 569 581
61. G.L. Smith, J.H. Lichtman, and M.B. Bracken Renal impairment and outcomes in heart failure: systematic review and meta-analysis J Am Coll Cardiol 47 2006 1987 1996
62. W. Mullens, Z. Abrahams, and G.S. Francis Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 2009 589 596
63. S.S. Gottlieb, D.C. Brater, and I. Thomas BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy Circulation 105 2002 1348 1353
64. Heart Failure Society of America Executive summary: HFSA 2006 comprehensive heart failure practice guideline J Card Fail 12 2006 10 38
65. B. Pitt, F. Zannad, and W.J. Remme Randomized Aldactone Evaluation Study Investigators.The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717